Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Thrive Future Habitats Limited

THRIVE
BSE
121.99
1.66%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Thrive Future Habitats Limited

THRIVE
BSE
121.99
1.66%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
138Cr
Close
Close Price
121.99
Industry
Industry
Personal Care
PE
Price To Earnings
PS
Price To Sales
97.93
Revenue
Revenue
1Cr
Rev Gr TTM
Revenue Growth TTM
-39.74%
PAT Gr TTM
PAT Growth TTM
-304.32%
Peer Comparison
How does THRIVE stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
THRIVE
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
331111011000
Growth YoY
Revenue Growth YoY%
-45.6-11.7-50.7-59.4-68.6-79.4-85.2-45.7-19.5-55.268.2-87.3
Expenses
ExpensesCr
552221011110
Operating Profit
Operating ProfitCr
-2-1-10-10000000
OPM
OPM%
-89.7-44.9-45.0-39.7-139.0-25.4-68.2-6.3-24.2-80.0-100.0-250.0
Other Income
Other IncomeCr
00-814000-3001
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000000000
PBT
PBTCr
-3-2-903000-3001
Tax
TaxCr
000010000000
PAT
PATCr
-3-2-902000-3000
Growth YoY
PAT Growth YoY%
-8.732.9-517.094.1168.897.498.5-28.6-249.0-600.0-200.0288.9
NPM
NPM%
-110.3-47.7-633.6-12.1241.5-6.0-63.6-28.6-447.0-93.3-113.5425.0
EPS
EPS
-6.2-3.3-20.2-0.34.3-0.1-0.3-0.4-6.3-0.3-0.40.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
677710191312721
Growth
Revenue Growth%
15.4-1.710.735.695.9-30.5-9.4-44.7-67.6-35.3
Expenses
ExpensesCr
7879132020211032
Operating Profit
Operating ProfitCr
-1-1-1-1-3-1-6-9-4-1-1
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-23.6-68.8
Other Income
Other IncomeCr
020014005-2-2
Interest Expense
Interest ExpenseCr
00000000000
Depreciation
DepreciationCr
00000001110
PBT
PBTCr
-11-1-1-33-7-9-3-3-3
Tax
TaxCr
00000100100
PAT
PATCr
-10-1-1-32-7-9-4-3-3
Growth
PAT Growth%
131.5-449.0-40.7-109.4152.4-563.7-31.455.921.3-4.5
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.2-234.8
EPS
EPS
-3.10.8-5.6-4.6-8.93.2-14.8-19.5-8.6-6.8-6.7

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
333445555510
Reserves
ReservesCr
03124916116421
Current Liabilities
Current LiabilitiesCr
4423118610311
Non Current Liabilities
Non Current LiabilitiesCr
00110011000
Total Liabilities
Total LiabilitiesCr
61069171924198425
Current Assets
Current AssetsCr
33449101410412
Non Current Assets
Non Current AssetsCr
36358910104223
Total Assets
Total AssetsCr
61069171924198425

Cash Flow

Consolidated
Standalone
Financial YearMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
9-4-1-4-7-9-710
Investing Cash Flow
Investing Cash FlowCr
-34-334-1000
Financing Cash Flow
Financing Cash FlowCr
0031313000
Net Cash Flow
Net Cash FlowCr
600103-610
Free Cash Flow
Free Cash FlowCr
50-2-4-6-10-710
CFO To PAT
CFO To PAT%
3,400.1363.441.2128.9-471.9124.374.2-21.7-5.5
CFO To EBITDA
CFO To EBITDA%
-701.4441.643.8118.3650.6134.978.9-23.4-33.7

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
361113134035221531
Price To Earnings
Price To Earnings
0.020.10.00.00.027.00.00.00.00.0
Price To Sales
Price To Sales
0.60.81.71.81.32.12.61.82.214.4
Price To Book
Price To Book
1.41.03.02.31.63.01.71.51.43.5
EV To EBITDA
EV To EBITDA
-5.2-3.8-13.5-9.6-3.8-36.3-4.7-2.6-4.0-61.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
28.533.127.427.126.334.427.421.2-2.930.1
OPM
OPM%
-17.1-20.1-12.1-17.6-31.5-5.6-47.5-70.4-55.5-23.6
NPM
NPM%
-15.24.2-14.7-18.7-28.97.7-51.6-74.8-59.8-145.2
ROCE
ROCE%
-22.015.5-19.9-23.7-34.021.0-31.3-58.5-27.4-34.1
ROE
ROE%
-37.15.1-25.5-24.8-36.411.1-33.4-59.8-36.4-34.9
ROA
ROA%
-14.32.9-15.5-15.6-16.87.8-28.9-47.7-49.6-85.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
#### **Overview** Ador Multi Products Limited (AMPL), established in 1986, is a prominent India-based contract manufacturer in the personal care sector and a key player in India’s evolving clean beauty and sustainable personal care ecosystem. As part of the 115-year-old Ador Group, AMPL has transformed from a traditional manufacturer of skincare and grooming products into a diversified, vertically integrated business focused on **contract manufacturing as a service (MaaS)**, **brand development**, and **direct-to-consumer (D2C) platform building**. With a manufacturing facility in Puducherry and over 40 years of operational legacy, AMPL serves leading national and international brands while simultaneously building its own portfolio of high-growth D2C brands. The company is currently undergoing a strategic transformation under new management and fresh capital infusion, aiming to expand into **real estate development** as a parallel growth and financial resilience lever. --- #### **Core Business Segments & Strategic Focus** ##### **1. Contract Manufacturing & Third-Party Services** AMPL is a **market leader in hand sanitizers**, attributed to one of India’s largest alcohol production capacities. It provides end-to-end manufacturing services for: - Hand sanitizers - Hand wash - Skincare (serums, face wash, moisturizers) - Talcum powder - Hair care - Body care It operates a fully **ISO-certified facility in Puducherry** with dual production lines (liquids/creams and talcum powder) and holds key regulatory licenses: **Ayurvedic, Ayush, cosmetic, pharmaceutical, and alcohol manufacturing permits**, ensuring compliance across diverse product categories. **Key Capabilities:** - Flexible minimum order quantities (MOQs) ideal for startups and agile brands - Packaging options: bottles, tubes, drums (up to 50L) - Enhanced automation, including a dedicated **tube filling line** for serums and gels - In-house **R&D, formulation**, and **testing labs** (under development for clinical validation) - Digital library of **5,000+ plug-and-play formulations** - Full supply chain management, including import of niche raw materials **Client Base:** - **Established FMCG Brands**: Himalaya Drug Company, Wipro, TTK, Argus, VLCC - **Emerging D2C Brands**: Baypure, Cocomo, Inde Wild - **Global/D2C Clients**: Unilever, international skincare brands in incubation --- ##### **2. Own & Partnered Brands – Building a "House of Brands"** AMPL is strategically pivoting toward higher-margin branded businesses through **acquisitions**, **joint ventures**, and **exclusive brand partnerships**. It manages and owns stakes in several subsidiaries and brands, aiming to create a scalable **"House of Brands"** model. **Subsidiary & Key Entity:** - **1908 E-Ventures Pvt. Ltd.** – A subsidiary and sister concern, founded in 2016, which operates: - **Sublime Life (www.sublimelife.in)**: India’s largest **clean and sustainable beauty platform**, recognized as the **only plastic-neutral-certified** e-commerce site in the sector. - Hosts **150–200+ global and domestic brands**, including Martiderm (Spain), Faith in Nature (UK), Cowshed (UK), and K-beauty labels. - Strong digital presence with **~70,000 Instagram followers**, live shopping, influencer marketing, and a **cosmetologist-led consultation service**. - Raised $2M in 2022 from **Roots Ventures** and prominent HNIs to scale operations. **Brand Portfolio (Owned, Joint Venture, & Exclusive Partnerships):** | Brand | Type | Details | |------|------|--------| | **Coccoon** | Acquired | Youth-focused skincare/haircare brand (launched 2017); paraben-free, clinically tested; 18+ SKUs, expansion plans for 30+ new launches. | | **Santic** | Acquired | D2C home cleaning & hygiene brand; 25+ products, with monthly new SKU rollout strategy. | | **Anatomicals Ador India Pvt. Ltd.** (JV) | Joint Venture with Anatomicals UK | Manufactures and distributes locally; sells via Shopify, expanding to marketplaces and retail. MoU signed for export to USA & Middle East. | | **23 Yards** | Joint Venture | With cricket legend **Ravi Shastri**; men’s grooming brand with digital and offline expansion plans. | | **Be the Solution** | In-house | Hand and seat sanitizers; launched during pandemic to meet hygiene demand. | | **Booth & Berkeley** | In-house | Amazon-exclusive men’s grooming line. | | **Influence** | In-house | Part of D2C portfolio; targeted at youth and influencer communities. | AMPL’s brand strategy is centered on **clean ingredients, sustainability, digital-first reach, and clinical efficacy**, aligned with rising consumer preference for ethical and transparent beauty. --- ##### **3. D2C & E-Commerce Platform (Sublime Life Ecosystem)** The **Sublime Life platform** is a critical growth engine, combining **branded product retail**, **platform-as-a-service for emerging brands**, and **content monetization (Sublime Stories)**. It averages **200+ orders per day**, with an AOV of ~₹1,250 and has served **150,000+ customers**. The platform supports: - **End-to-end brand acceleration**: From concept to market (R&D, manufacturing, testing, packaging, distribution, marketing) - **E-commerce fulfillment** and influencer campaigns - **Offline presence**: First **experiential store opened in Gurgaon** (2022) - **Live shopping, podcast series, and digital content** The company plans to grow the platform to **4,000+ products** and **200+ brands** within the next three years. --- ##### **4. Strategic Partnerships & Expansion** - **Exclusive International Tie-Ups**: Martiderm (Spain), Faith in Nature, Cowshed (UK), and upcoming launch of a French brand. - **Sustainability Collaborations**: With **Mend Packaging** (eco-friendly packaging) and **Climes** (carbon-neutral impact). - **Technology & Infrastructure**: Partnering with Amazon India for brand distribution and e-commerce expansion. --- #### **Financial & Operational Highlights** - **Revenue (Jul 2025 Review Period)**: ₹217.97 lakhs (down from ₹515.14 lakhs YoY) – attributed to reduced sanitizer demand post-pandemic and raw material supply disruptions. - **Previous Revenue (FY23)**: ₹588.75 lakhs (down from ₹720.81 lakhs) due to similar macro headwinds. - **D2C Contribution**: Accounted for **50% of revenue in FY22**, indicating strong traction in branded operations. - **Cost Optimization**: Shifted to a **single, high-capacity Puducherry factory**, improving productivity and reducing overheads. - **Margin Strategy**: Reduced marketing spend on legacy brands; focused on high-margin contract manufacturing and owned brands. --- #### **Leadership & Management Transformation** - **New Management & Investor Influx**: A restructured leadership team backed by fresh capital is driving strategic renewal, including **diversification into real estate**. - **Mr. Vinay Kumar Singh (Appointed May 2025)**: - Former **Founding MD of NCRTC**, led India’s first **Regional Rapid Transit System (Namo Bharat)**. - Bringing large-scale **infrastructure and project execution expertise** to lead AMPL’s **luxury real estate ventures**. - Strategic intent: Use real estate to **generate stable cash flows**, support long-term growth, and de-risk the business. --- #### **Competitive Strengths** - Fully **integrated value chain** (R&D, manufacturing, testing, supply chain, e-commerce) - Strong **B2B client relationships** and **repeat business** from FMCG leaders - **Agile manufacturing model** supporting startups and global brands - **Strategic shift to D2C and premium clean beauty** with high-margin potential - **Scalable infrastructure** and compliance certifications - **Geographical advantage** of Puducherry facility for South Indian and export logistics